Cargando…

High expression of autophagy-related gene EIF4EBP1 could promote tamoxifen resistance and predict poor prognosis in breast cancer

BACKGROUND: Breast cancer (BC) remains a public health problem. Tamoxifen (TAM) resistance has caused great difficulties for treatment of BC patients. Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1) plays critical roles in the tumorigenesis and progression of BC. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shan, Hui, Tian-Li, Wang, Hao-Qi, Zhang, Xi, Mi, Yun-Zhe, Cheng, Meng, Gao, Wei, Geng, Cui-Zhi, Li, Sai-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Clinical and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424051/ https://www.ncbi.nlm.nih.gov/pubmed/37583983 http://dx.doi.org/10.12998/wjcc.v11.i20.4788

Ejemplares similares

Regulation of tamoxifen sensitivity by a PAK1–EBP1 signalling pathway in breast cancer
por: Ghosh, A, et al.
Publicado: (2013)

EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
por: Voeltzke, Kai, et al.
Publicado: (2022)

EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma
por: Cha, Yin-Lian, et al.
Publicado: (2015)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

Overexpression of p-4EBP1 associates with p-eIF4E and predicts poor prognosis for non-small cell lung cancer patients with resection
por: Tang, Yaoxiang, et al.
Publicado: (2022)

p53 mutation, deprivation and poor prognosis in primary breast cancer
por: Baker, L, et al.
Publicado: (2010)

Autophagy-related long non-coding RNA prognostic model predicts prognosis and survival of melanoma patients
por: Qiu, Yue, et al.
Publicado: (2022)

An α-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen
por: Andersen, T T, et al.
Publicado: (2007)

Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
por: Cabalag, Carlos S., et al.
Publicado: (2022)

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients
por: Bai, Tuya, et al.
Publicado: (2017)

BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma
por: Wan, Pei, et al.
Publicado: (2020)

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate
por: Scandlyn, M J, et al.
Publicado: (2008)

Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
por: Garvin, S, et al.
Publicado: (2005)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma
por: Fiaschetti, G, et al.
Publicado: (2014)

HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer
por: Abdel-Fatah, T M A, et al.
Publicado: (2014)

The eIF4EBP-eIF4E axis regulates CD4(+) T cell differentiation through modulation of T cell activation and metabolism
por: Istomine, Roman, et al.
Publicado: (2023)

High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer
por: Li, Fan, et al.
Publicado: (2021)

Low EIF2B5 expression predicts poor prognosis in ovarian cancer
por: Hou, Lin, et al.
Publicado: (2020)

MR1 overexpression correlates with poor clinical prognosis in glioma patients
por: Kubica, Phillip, et al.
Publicado: (2021)

Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
por: Nagata, M, et al.
Publicado: (2011)

eif4ebp3l—A New Affector of Zebrafish Angiogenesis and Heart Regeneration?
por: Born, Lisa I., et al.
Publicado: (2022)

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases
por: Nagy, E, et al.
Publicado: (2014)

Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma
por: Jacobson, B A, et al.
Publicado: (2009)

Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer
por: Mokutani, Yukako, et al.
Publicado: (2016)

Metformin blocks MYC protein synthesis in colorectal cancer via mTOR‐4EBP‐eIF4E and MNK1‐eIF4G‐eIF4E signaling
por: Shen, Peng, et al.
Publicado: (2018)

CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
por: Dubrovska, A, et al.
Publicado: (2012)

Role of endoplasmic reticulum stress induction by the plant toxin, persin, in overcoming resistance to the apoptotic effects of tamoxifen in human breast cancer cells
por: McCloy, R A, et al.
Publicado: (2013)

CD44(+)CD24(−) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
por: Hurt, E M, et al.
Publicado: (2008)

Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis
por: Masuda, Shigeto, et al.
Publicado: (2023)

High expression of eIF4A2 is associated with a poor prognosis in esophageal squamous cell carcinoma
por: Lyu, Shanshan, et al.
Publicado: (2020)

High expression of eIF3d is associated with poor prognosis in patients with gastric cancer
por: He, Jiaqi, et al.
Publicado: (2017)

Targeting of EIF4EBP1 by miR‐99a‐3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression
por: Yang, Meng, et al.
Publicado: (2021)

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
por: Lu, Weiyu, et al.
Publicado: (2023)

Phosphorylated Mnk1 and eIF4E Are Associated with Lymph Node Metastasis and Poor Prognosis of Nasopharyngeal Carcinoma
por: Zheng, Jun, et al.
Publicado: (2014)

The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials
por: Karlsson, Elin, et al.
Publicado: (2013)

Overexpression of AMPD2 indicates poor prognosis in colorectal cancer patients via the Notch3 signaling pathway
por: Gao, Qi-Zhong, et al.
Publicado: (2020)

Could the eIF2α-Independent Translation Be the Achilles Heel of Cancer?
por: Holcik, Martin
Publicado: (2015)

Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assembly
por: Frosi, Yuri, et al.
Publicado: (2019)

The pro-apoptotic role of autophagy in breast cancer
por: Suman, S, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7tu1dl30smmegn0uf8srgviqns